IMV Inc IMVIF

AARC Presentation,DPX Platform Recognition,or Partnership?

[Hideaway]

IMV seems to finally be getting some recognition amongst investors.All the above are possible drivers but just speculation at the moment.The AARC presentation on April 12th could provide some clarification barring some announcements beforehand.However,three weeks is a long time to wait especially in the current environment.If we can hold our gains going into the 12th,it IMHO, that would be a good omen.
Obviously the Company cannot confirm or deny any future announcements.Do any other posters have additional info or comments?

[alphaseeking001]

No additional info Hideaway.  I spoke with IR about 6 weeks ago because I was frustrated and he seemed pretty upbeat but I've learned not to read much into that.  The late breaking presentation seems like a pretty positive sign.  We do seem to have more and more irons in the fire so I'll hold the shares I rebought at $2.20 in the fall.  If anyone else has any recent

[Biotech010]

CFO Pierre sais on a webcast in 2021 that a license deal was possible in Q1 2022. Now that Q1 is almost over...a deal should be coming soon. The CEO is now pushing on with the DPX platform.... so we should get news very soon!